Prognostic significance of infectious episodes occurring during first-line therapy for diffuse large B-cell lymphoma - A nationwide cohort study.

MLA

Clausen, Michael R., et al. “Prognostic Significance of Infectious Episodes Occurring during First-Line Therapy for Diffuse Large B-Cell Lymphoma - A Nationwide Cohort Study.” Hematological Oncology, vol. 38, no. 3, Aug. 2020, pp. 318–25. EBSCOhost, https://doi.org/10.1002/hon.2734.

APA

Clausen, M. R., Ulrichsen, S. P., Juul, M. B., Poulsen, C. B., Iversen, B., Pedersen, P. T., Madsen, J., Pedersen, R. S., Josefsson, P. L., Gørløv, J. S., Nørgaard, M., & d’Amore, F. (2020). Prognostic significance of infectious episodes occurring during first-line therapy for diffuse large B-cell lymphoma - A nationwide cohort study. Hematological Oncology, 38(3), 318–325. https://doi.org/10.1002/hon.2734

Chicago

Clausen, Michael R, Sinna P Ulrichsen, Maja B Juul, Christian B Poulsen, Brian Iversen, Per T Pedersen, Jakob Madsen, et al. 2020. “Prognostic Significance of Infectious Episodes Occurring during First-Line Therapy for Diffuse Large B-Cell Lymphoma - A Nationwide Cohort Study.” Hematological Oncology 38 (3): 318–25. doi:10.1002/hon.2734.